|
DAG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.489970E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.852640E-01 |
| Normal-vs-Stage2 |
4.628400E-01 |
| Normal-vs-Stage3 |
3.648800E-01 |
| Normal-vs-Stage4 |
1.920180E-01 |
| Stage1-vs-Stage2 |
8.975200E-01 |
| Stage1-vs-Stage3 |
7.855200E-01 |
| Stage1-vs-Stage4 |
7.665200E-01 |
| Stage2-vs-Stage3 |
9.484600E-01 |
| Stage2-vs-Stage4 |
7.246400E-01 |
| Stage3-vs-Stage4 |
6.161600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.095700E-02 |
| Normal-vs-AfricanAmerican |
5.036300E-02 |
| Normal-vs-Asian |
1.809350E-01 |
| Caucasian-vs-AfricanAmerican |
3.912000E-01 |
| Caucasian-vs-Asian |
7.600600E-01 |
| AfricanAmerican-vs-Asian |
6.046200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.963000E-01 |
| Normal-vs-Female |
8.350100E-02 |
| Male-vs-Female |
1.754410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.097640E-01 |
| Normal-vs-Age(41-60Yrs) |
1.929820E-01 |
| Normal-vs-Age(61-80Yrs) |
7.350800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.959000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.805000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.992240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.703840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.569200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.433600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.203800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.283600E-01 |
| Classical-VS-Follicular |
1.1698000346172E-09 |
| Classical-VS-Other |
6.902000E-02 |
| Classical-VS-Normal |
2.860500E-03 |
| Tall-VS-Follicular |
8.606100E-04 |
| Tall-VS-Other |
8.820500E-02 |
| Tall-VS-Normal |
1.232570E-01 |
| Follicular-VS-Other |
8.550800E-01 |
| Follicular-VS-Normal |
1.613900E-02 |
| Other-VS-Normal |
2.963800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.365400E-01 |
| Normal-vs-N1 |
7.457400E-01 |
| N0-vs-N1 |
9.127600E-01 |
|
|
